AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · CAHealthcareBiotechnology
$15.25-4.45%
Price as of Jul 20, 2026
AUPH valuation
Aurinia Pharmaceuticals Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 34.98x
- P/E 2026E
- 18.29x
- P/E 2027E
- 13.15x
- P/E 2028E
- 9.09x
- P/S forward
- 11.81x
Trailing multiples
- P/E TTM
- 6.81x
- PEG TTM
- —
- Price / book
- 3.46x
- Price / sales
- 6.57x
- Price / cash flow
- 11.83x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 5.53x
- EV / EBITDA
- 10.21x
- EV / EBIT
- 13.26x
- Market cap
- $2.0B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.